Constarium
← Search

Data · dataset · 2026

POLAR Trial | WES | cfDNA | mIF Correlative raw data and R script

Listed in DataCite

This dataset contains processed clinical, genomic, and transcriptomic data from the POLAR clinical trial, evaluating pembrolizumab and olaparib in metastatic pancreatic cancer with or without homologous recombination deficiency (HRD).

Description

Data include mutation calls (WES), RNA-seq expression matrices, neoantigen predictions, and associated de-identified clinical annotations. Integrated analyses link genomic instability and neoantigen burden to immune infiltration and clinical outcomes.

Links

Topics

Stated by source
Basic medicine · Basic medicine
Inferred from text
Cancer 75% · RNA sequencing 65%
Provenance · 2 source records, 13 field assertions
SourceKeyLast seenRaw
DataCite10.6084/m9.figshare.298742157 d agoJSON v1
DataCite10.6084/m9.figshare.29874215.v17 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · DataCiteconnector:datacite@1.0.0/data/attributes/rightsList
byte_sizesource · DataCiteconnector:datacite@1.0.0
concepts[disease].local:disease:cancerenrichment · DataCitekeyword-concept-rules@1.0.0title+description (75%)
concepts[field].fos:basic-medicinesource · DataCiteconnector:datacite@1.0.0
concepts[field].fos:basic-medicinesource · DataCiteconnector:datacite@1.0.0
concepts[modality].local:modality:rna-seqenrichment · DataCitekeyword-concept-rules@1.0.0title+description (65%)
created_datesource · DataCiteconnector:datacite@1.0.0
descriptionsource · DataCiteconnector:datacite@1.0.0/data/attributes/descriptions
licensesource · DataCiteconnector:datacite@1.0.0/data/attributes/rightsList
publication_datesource · DataCiteconnector:datacite@1.0.0/data/attributes/dates
titlesource · DataCiteconnector:datacite@1.0.0/data/attributes/titles/0/title
updated_datesource · DataCiteconnector:datacite@1.0.0
version_labelsource · DataCiteconnector:datacite@1.0.0